These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26384640)

  • 1. Re: 'Prothrombin G20210 Mutation and Lower Extremity Peripheral Arterial Disease: A Systematic Review and Meta-analysis'.
    Boulon C; Berard A; Freyburger G; Constans J
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):827. PubMed ID: 26384640
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to 'Re: Prothrombin G20210A Mutation and Lower Extremity Peripheral Arterial Disease. A Systematic Review and Meta-analysis'.
    Vazquez F; Gandara E
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):827-8. PubMed ID: 26409705
    [No Abstract]   [Full Text] [Related]  

  • 3. Prothrombin G20210A mutation and lower extremity peripheral arterial disease: a systematic review and meta-analysis.
    Vazquez F; Rodger M; Carrier M; Le Gal G; Reny JL; Sofi F; Mueller T; Nagpal S; Jetty P; Gandara E
    Eur J Vasc Endovasc Surg; 2015 Aug; 50(2):232-40. PubMed ID: 26092622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple arterial thromboembolisms in a patient with the 20210 A prothrombin gene mutation.
    Seeburger JL; Stepak M; Fukuchi SG; Siegel JE; Rolandelli RH
    Arch Surg; 2000 Jun; 135(6):721-2. PubMed ID: 10843373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute coronary and peripheral arterial thrombosis following percutaneous coronary intervention in a patient with previously undiagnosed inherited thrombophilia.
    Nanas JN; Gougoulakis A; Kanakakis J
    Can J Cardiol; 2003 Aug; 19(9):1063-5. PubMed ID: 12915935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombophilic risk factors and peripheral arterial disease severity.
    Sartori M; Favaretto E; Legnani C; Cini M; Conti E; Amato A; Palareti G
    Thromb Haemost; 2010 Jul; 104(1):71-7. PubMed ID: 20390230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial vein thrombosis in non-varicose veins of the lower limbs and thrombophilia.
    Lucchi G; Bilancini S; Tucci S; Lucchi M
    Phlebology; 2018 May; 33(4):278-281. PubMed ID: 28134019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Study on Hereditary Thrombophilia and Stroke in a Cohort from Sri Lanka.
    Kalpage HA; Sumathipala DS; Goonasekara HW; Dissanayake VH
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):102-9. PubMed ID: 26522268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies and lower extremity peripheral arterial disease - a systematic review and meta-analysis.
    Gavier B; Vazquez F; Gandara E
    Vasa; 2016; 45(4):325-30. PubMed ID: 27428502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for thrombophilia in extrahepatic portal vein obstruction.
    Primignani M; Martinelli I; Bucciarelli P; Battaglioli T; Reati R; Fabris F; Dell'era A; Pappalardo E; Mannucci PM
    Hepatology; 2005 Mar; 41(3):603-8. PubMed ID: 15726653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Unexpectedly High Rate of Thrombophilia Disorders in Patients with Superficial Vein Thrombosis of the Lower Extremities.
    Sobreira ML; Rogatto SR; Dos Santos RM; Santos IT; Ferrari IC; Yoshida WB
    Ann Vasc Surg; 2017 Aug; 43():272-277. PubMed ID: 28501666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leg ulcers revealing familial thrombophilia: prothrombin G20210A gene mutation and plasminogen activator inhibitor type 1 (PAI-1) polymorphism.
    Calistru AM; Cruz MJ; Baudrier T; Gonçalves L; Azevedo F
    Eur J Dermatol; 2011; 21(3):414-5. PubMed ID: 21515439
    [No Abstract]   [Full Text] [Related]  

  • 13. Ocular artery thrombosis as an initial presentation of a prothrombin G20210A mutation.
    Parc C; Tiberghien E; Pierre-Kahn V
    J Fr Ophtalmol; 2010 Jun; 33(6):380-2. PubMed ID: 20493583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the clinical relevance of the prothrombin G20210A mutation?
    Lowe G
    Atherosclerosis; 2010 Feb; 208(2):330-1. PubMed ID: 20036364
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reccurent pregnancy loss and 20210GA prothrombin mutation].
    Oukkach B; Igala M; Lamchahab M; Dehbi H; Faez S; Nadifi S; Benchekroun S
    Ann Biol Clin (Paris); 2013; 71(1):96-8. PubMed ID: 23396431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper-extremity deep vein thrombosis in a patient on clozapine therapy carrying the prothrombin G20210A mutation.
    Vayá A; Lopez M; Plumé G; Ribes J
    Pathophysiol Haemost Thromb; 2008; 36(2):105-7. PubMed ID: 19127092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Painful congestion of the lower limbs and recurrent fever.
    Staubach S; Hug M; Mudra H
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):752-5. PubMed ID: 21885950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.
    Cosmi B; Legnani C; Pengo V; Ghirarduzzi A; Testa S; Poli D; Prisco D; Tripodi A; Palareti G;
    Thromb Haemost; 2013 Mar; 109(3):510-6. PubMed ID: 23306310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual cause of cerebral venous sinus thrombosis: prothrombin G20210A gene mutation.
    Porres-Aguilar M; Square JH; Storey R; Rodriguez-Dunn S; Mohamed-Aly MS
    South Med J; 2007 Sep; 100(9):906-8. PubMed ID: 17902293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.